Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Strategy in Rheumatology When Faced With a Patient Treated With Methotrexate (MTX) for Rheumatoid Arthritis (RA).

NCT02288520 is registered in ClinicalTrials.gov with Nordic Pharma SAS as lead sponsor.

NCT NCT02288520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02288520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Strategy in Rheumatology When Faced With a Patient Treated With Methotrexate (MTX) for Rheumatoid Arthritis (RA).
Lead sponsor
Nordic Pharma SAS
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
March 31, 2016
Enrollment
854 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis